The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I/II, first-in-human dose-escalation study of GSK2636771 in patients (pts) with PTEN-deficient advanced tumors.
Hendrik-Tobias Arkenau
No relevant relationships to disclose
Joaquin Mateo
No relevant relationships to disclose
Charlotte Rose Lemech
No relevant relationships to disclose
Jeffrey R. Infante
Consultant or Advisory Role - GlaxoSmithKline (U)
Howard A. Burris
No relevant relationships to disclose
Yung-Jue Bang
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Joseph Paul Eder
No relevant relationships to disclose
Roy S. Herbst
No relevant relationships to disclose
Sunil Sharma
Research Funding - GlaxoSmithKline
Hyun Cheol Chung
No relevant relationships to disclose
Shaun Decordova
No relevant relationships to disclose
Karen E Swales
No relevant relationships to disclose
Michelle D Garrett
No relevant relationships to disclose
Jill I Loftiss
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Michael Durante
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Mark W. Russo
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Benjamin B. Suttle
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Monica Motwani
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Rakesh Kumar
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Johann Sebastian De Bono
No relevant relationships to disclose